Statistics
Publications
22
Citations
3.7K
H-Index
19
Active since
1966
Thomas Holcomb is an author at Colorado State University specializing in oncology, medicine, and life sciences.
Publications per year
1966–2020
22
22
Treatment of Medulloblastoma with Hedgehog Pathway Inhibitor GDC-0449
Charles M. Rudin, Christine L. Hann, John Laterra et al. · New England Journal of Medicine · 2009 · 1K citations · Full text
Medicine, Oncology, Pharmacology +17
<i>Smoothened</i> Mutation Confers Resistance to a Hedgehog Pathway Inhibitor in Medulloblastoma
Robert L. Yauch, Gerrit J.P. Dijkgraaf, Bruno Alicke et al. · Science · 2009 · 844 citations · Full text
Medicine, Cancer Biology, Oncology +17
Somatic Mutations Lead to an Oncogenic Deletion of Met in Lung Cancer
Monica Kong-Beltran, Somasekar Seshagiri, Jiping Zha et al. · Cancer Research · 2006 · 483 citations
Medicine, Cancer Biology, Oncology +17
Recurrent Loss of NFE2L2 Exon 2 Is a Mechanism for Nrf2 Pathway Activation in Human Cancers
Leonard D. Goldstein, James Lee, Florian Gnad et al. · Cell Reports · 2016 · 211 citations · Full text
1–5 of 22